Follow The Filings

ACRV Acrivon Therapeutics Inc.

Health Care, filed as ACRIVON THERAPEUTICS INC (COMMON STOCK), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by ACRV's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ACRV insider trades
  • $114K bought by 3 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Peter Blume-Jensen CEO, +1 joint filer
    Buy
    $82K 49,000 shares at $1.68 +2.4% to stake
    Traded Jan 14 Filed Jan 16
    ↗
  2. Adam D. Levy CFO
    Buy
    $15K 8,832 shares at $1.70 +73% to stake
    Traded Jan 14 Filed Jan 16
    ↗
  3. Eric Devroe COO
    Buy
    $17K 10,000 shares at $1.72 +15% to stake
    Traded Jan 13 Filed Jan 15
    ↗

Also filed in the last 12 months, not counted as buying or selling: 23 share withholdings for taxes, 17 stock grants, and 11 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 5 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$60.39M -$80.56M -$77.9M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $129.69M $181.63M $120.44M
Total non-current assets * $8.57M $14.96M $9.27M
Total assets $138.26M $196.59M $129.72M
Total current liabilities $13.3M $17.21M $15.66M
Total non-current liabilities * $3.77M $2.59M $1.54M
Total equity $121.2M $176.79M $112.52M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$42.64M -$65.67M -$63.66M
Cash from investing $50.72M -$51.77M $66.1M
Cash from financing -$1.55M $121.03M -$0.749M
Net change in cash $6.52M $3.59M $1.69M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.